Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › AR › NORTH LITTLE ROCK › BAPTIST HEALTH

BAPTIST HEALTH

NPI: 1497790042 · NORTH LITTLE ROCK, AR 72117 · Rehabilitation Clinic/Center · NPI assigned 06/18/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WELLS, TROY controls 20+ related entities in our dataset. Read more

$14.02M
Total Medicaid Paid
846,076
Total Claims
686,128
Beneficiaries
301
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWELLS, TROY (PRESIDENT)
NPI Enumeration Date06/18/2006

Related Entities

Other providers sharing the same authorized official: WELLS, TROY

ProviderCityStateTotal Paid
BAPTIST HEALTH REGIONAL HOSPITALS FORT SMITH AR $17.49M
BAPTIST HEALTH LITTLE ROCK AR $16.48M
BAPTIST HEALTH ARKADELPHIA AR $4.82M
CONWAY COMMUNITY SERVICES CONWAY AR $4.12M
BAPTIST HEALTH HEBER SPRINGS AR $3.69M
BAPTIST HEALTH HOSPITALS STUTTGART AR $2.97M
BAPTIST HEALTH LITTLE ROCK AR $2.93M
BAPTIST HEALTH MALVERN AR $2.68M
BAPTIST HEALTH REGIONAL HOSPITALS VAN BUREN AR $2.46M
BAPTIST HEALTH LITTLE ROCK AR $1.83M
BAPTIST HEALTH ARKADELPHIA AR $1.51M
BAPTIST HEALTH HOSPITALS STUTTGART AR $901K
BAPTIST HEALTH LITTLE ROCK AR $780K
BAPTIST HEALTH NORTH LITTLE ROCK AR $411K
BAPTIST HEALTH MONTICELLO AR $367K
BAPTIST HEALTH CONWAY AR $142K
BAPTIST HEALTH LITTLE ROCK AR $88K
BAPTIST HEALTH PRESCOTT AR $33K
BAPTIST HEALTH MALVERN AR $31K
BAPTIST HEALTH HEBER SPRINGS AR $22K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 123,855 $1.47M
2019 137,523 $1.99M
2020 113,014 $1.75M
2021 122,251 $2.17M
2022 129,700 $2.47M
2023 133,328 $2.56M
2024 86,405 $1.61M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80047 33,361 28,175 $995K
70450 Computed tomography, head or brain; without contrast material 8,353 7,434 $720K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 6,610 6,045 $688K
74177 Computed tomography, abdomen and pelvis; with contrast material 5,235 4,701 $654K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 4,591 2,087 $606K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 2,141 1,779 $444K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 4,406 3,769 $432K
71275 Computed tomographic angiography, chest, with contrast material 2,073 1,889 $379K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 46,888 37,973 $333K
80048 Basic metabolic panel (calcium, ionized) 13,217 10,567 $315K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,719 2,411 $287K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 27,463 22,488 $272K
36415 Collection of venous blood by venipuncture 53,309 44,379 $267K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 8,418 3,124 $260K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 6,070 5,283 $256K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4,288 3,748 $238K
74176 Computed tomography, abdomen and pelvis; without contrast material 3,555 3,212 $230K
72125 Computed tomography, cervical spine; without contrast material 1,895 1,716 $210K
71046 Radiologic examination, chest; 2 views 14,285 12,519 $209K
93975 2,720 2,414 $196K
J2785 Injection, regadenoson, 0.1 mg 1,319 1,087 $181K
87631 2,158 1,978 $162K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1,981 1,668 $157K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1,632 1,343 $156K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 3,031 2,808 $137K
80076 12,762 11,140 $133K
T1015 Clinic visit/encounter, all-inclusive 11,436 9,236 $128K
70551 Magnetic resonance imaging, brain; without contrast material 592 502 $122K
84703 13,026 11,465 $119K
80051 6,059 5,357 $108K
77067 Screening mammography, bilateral, including computer-aided detection 2,200 2,108 $108K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 12,635 11,149 $106K
86901 4,793 4,062 $104K
83880 4,786 4,052 $104K
84484 14,292 10,726 $100K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 367 306 $100K
97530 Therapeutic activities, direct patient contact, each 15 minutes 3,714 1,545 $94K
72141 506 397 $91K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 5,238 4,235 $83K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 10,433 8,603 $82K
96361 Intravenous infusion, hydration; each additional hour 6,951 5,403 $79K
71260 Computed tomography, thorax, diagnostic; with contrast material 680 603 $78K
82550 13,889 10,887 $73K
73560 2,488 2,158 $69K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 337 315 $69K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 925 857 $62K
97161 1,119 1,004 $61K
82962 7,929 4,108 $60K
83690 9,379 8,238 $60K
70486 516 461 $60K
84132 2,569 2,255 $59K
71250 729 661 $57K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,314 1,222 $55K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,314 1,222 $55K
74022 2,867 2,542 $55K
72100 2,281 2,036 $53K
81001 16,968 14,826 $51K
85027 7,697 6,338 $51K
36430 636 477 $51K
86900 4,794 4,062 $49K
87070 1,915 1,565 $48K
93971 1,292 1,141 $47K
76801 1,398 1,240 $47K
80306 3,025 2,538 $47K
87040 4,135 2,659 $46K
76000 972 883 $46K
81025 5,479 4,956 $46K
82947 10,206 7,374 $45K
96376 4,827 3,232 $44K
71045 Radiologic examination, chest; single view 6,397 5,419 $43K
83735 7,870 6,499 $42K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,179 947 $42K
83605 4,522 3,437 $42K
73630 1,607 1,423 $41K
96375 Therapeutic injection; each additional sequential IV push 9,075 7,577 $41K
82077 2,698 2,316 $40K
73030 1,839 1,635 $39K
84145 2,487 2,155 $38K
82565 7,658 6,730 $36K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 1,529 1,305 $36K
73130 1,426 1,252 $34K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 9,122 8,147 $34K
85379 3,918 3,518 $34K
J2405 Injection, ondansetron hydrochloride, per 1 mg 17,194 14,239 $33K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,069 1,838 $32K
90715 1,831 1,672 $30K
87088 4,236 3,776 $30K
80053 Comprehensive metabolic panel 2,157 1,703 $30K
81003 14,972 13,219 $30K
82803 1,894 1,594 $30K
J0696 Injection, ceftriaxone sodium, per 250 mg 7,226 5,864 $29K
80143 1,615 1,419 $28K
J1650 Injection, enoxaparin sodium, 10 mg 2,250 1,413 $28K
80179 1,593 1,402 $28K
84702 2,843 2,400 $28K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 140 103 $27K
85014 3,203 2,575 $27K
72040 1,119 1,013 $26K
82150 4,158 3,743 $25K
80320 1,979 1,598 $25K
73502 1,187 1,047 $25K
87077 2,804 2,424 $24K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2,065 1,358 $23K
73610 1,236 1,109 $23K
97165 449 402 $23K
85610 6,632 5,680 $23K
99283 Emergency department visit for the evaluation and management, moderate severity 3,009 2,664 $22K
93017 1,731 1,428 $21K
77066 Tomosynthesis, mammo 340 302 $21K
84520 6,230 5,509 $20K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,983 5,234 $20K
82375 1,970 1,675 $19K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 410 366 $18K
99284 Emergency department visit for the evaluation and management, high severity 4,744 4,237 $18K
74018 1,010 865 $18K
76642 634 576 $17K
85730 3,752 3,284 $17K
93458 252 220 $17K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 489 439 $16K
80050 General health panel 516 434 $16K
84443 Thyroid stimulating hormone (TSH) 1,589 1,340 $16K
12001 85 77 $16K
80061 Lipid panel 1,230 1,026 $16K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 4,264 3,534 $16K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2,250 1,935 $14K
97162 279 244 $14K
87486 340 318 $14K
87581 339 317 $14K
71020 1,158 1,064 $14K
J1885 Injection, ketorolac tromethamine, per 15 mg 10,781 9,153 $13K
86850 3,500 2,915 $13K
97001 546 450 $13K
76700 Ultrasound, abdominal, real time with image documentation; complete 360 300 $13K
77063 Screening digital breast tomosynthesis, bilateral 951 913 $13K
87086 Culture, bacterial; quantitative colony count, urine 1,711 1,551 $13K
76830 Ultrasound, transvaginal 306 256 $13K
10060 70 67 $13K
85018 3,274 2,612 $13K
80329 1,022 814 $13K
83036 Hemoglobin; glycosylated (A1C) 1,906 1,630 $13K
87186 2,278 1,964 $12K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1,175 1,026 $12K
85055 791 642 $12K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 314 285 $10K
87210 1,836 1,684 $10K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 556 470 $9K
82010 1,333 1,130 $9K
73110 446 392 $9K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1,945 1,763 $9K
88305 Level IV - Surgical pathology, gross and microscopic examination 198 180 $8K
70496 55 46 $7K
70498 55 45 $7K
76775 473 420 $7K
82805 304 245 $7K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 34 31 $7K
85007 2,421 2,072 $7K
80069 907 568 $7K
95811 75 65 $6K
82247 834 639 $6K
87205 2,065 1,690 $6K
94760 444 416 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 468 446 $5K
86923 369 302 $5K
J0690 Injection, cefazolin sodium, 500 mg 5,595 4,338 $5K
87075 1,062 846 $5K
72131 60 51 $5K
A6213 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing 642 338 $5K
J1815 Injection, insulin, per 5 units 4,421 2,484 $4K
51701 66 55 $4K
C1769 Guide wire 145 133 $4K
76536 80 73 $3K
0353U 531 486 $3K
93296 280 263 $3K
J3010 Injection, fentanyl citrate, 0.1 mg 10,339 8,403 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg 5,808 4,661 $3K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 196 192 $3K
97597 167 120 $3K
93880 113 105 $3K
82607 320 288 $3K
99152 1,317 1,146 $3K
82746 238 212 $2K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 325 299 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 43 41 $2K
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 199 187 $2K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 3,074 2,594 $2K
72070 155 139 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 137 123 $2K
73070 137 120 $2K
A9577 Injection, gadobenate dimeglumine (multihance), per ml 34 33 $2K
73590 93 76 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 2,116 1,606 $2K
J2704 Injection, propofol, 10 mg 6,026 5,358 $2K
J1644 Injection, heparin sodium, per 1000 units 3,867 2,252 $2K
93976 45 40 $2K
86140 363 309 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 67 62 $2K
77062 28 28 $2K
A9270 Non-covered item or service 14,044 3,094 $2K
71271 26 26 $2K
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 42 36 $2K
J2270 Injection, morphine sulfate, up to 10 mg 6,721 5,264 $2K
71010 260 242 $1K
80349 86 73 $1K
J2550 Injection, promethazine hcl, up to 50 mg 1,940 1,651 $1K
J1170 Injection, hydromorphone, up to 4 mg 4,337 3,544 $1K
82728 102 92 $1K
95810 Polysomnography; sleep staging with 4 or more additional parameters 17 12 $1K
J2060 Injection, lorazepam, 2 mg 1,250 1,009 $1K
A6197 Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing 229 140 $1K
93970 44 41 $1K
G0378 Hospital observation service, per hour 1,316 1,158 $1K
82330 67 59 $1K
73090 57 50 $1K
80324 55 44 $1K
P9016 Red blood cells, leukocytes reduced, each unit 542 419 $1K
0225U 175 164 $990.83
82800 92 88 $967.94
J0561 Injection, penicillin g benzathine, 100,000 units 14 13 $910.13
J1200 Injection, diphenhydramine hcl, up to 50 mg 2,539 2,097 $898.01
82248 184 163 $893.84
97003 29 24 $889.92
J1953 Injection, levetiracetam, 10 mg 40 26 $817.40
74000 60 47 $791.11
78264 28 24 $790.35
85652 302 270 $687.76
J7030 Infusion, normal saline solution , 1000 cc 7,780 6,213 $663.59
J3370 Injection, vancomycin hcl, 500 mg 387 292 $657.60
80346 28 26 $601.20
99282 Emergency department visit for the evaluation and management, low to moderate severity 12 12 $589.27
77065 Tomosynthesis, mammo 19 15 $524.36
94010 13 13 $521.71
87807 40 39 $494.38
84100 143 103 $442.58
90686 54 48 $432.72
A4364 Adhesive, liquid or equal, any type, per oz 43 38 $429.29
J0360 Injection, hydralazine hcl, up to 20 mg 2,550 2,066 $395.86
94729 13 12 $385.60
83550 63 55 $379.39
83540 78 69 $358.90
36600 2,103 1,777 $336.18
93283 13 13 $313.21
J7120 Ringers lactate infusion, up to 1000 cc 6,986 5,288 $287.23
J1940 Injection, furosemide, up to 20 mg 1,451 1,073 $278.10
29581 103 38 $267.01
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 167 141 $256.35
72080 12 12 $251.77
81015 315 277 $249.89
74019 15 15 $242.60
J2370 Injection, phenylephrine hcl, up to 1 ml 1,438 1,264 $229.09
72170 17 17 $208.84
87340 41 40 $206.50
73140 15 12 $194.42
84295 44 38 $192.36
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 42 41 $190.00
82435 44 38 $183.68
J2765 Injection, metoclopramide hcl, up to 10 mg 467 402 $183.14
93242 15 14 $180.21
82570 30 24 $175.63
86308 18 12 $137.26
97535 Self-care/home management training, each 15 minutes 402 328 $133.94
84439 16 13 $115.92
0202U Oncology (prostate), multianalyte, gene expression profiling 16 13 $88.50
83615 16 13 $77.67
J2175 Injection, meperidine hydrochloride, per 100 mg 322 253 $73.79
J1596 Injection, glycopyrrolate, 0.1 mg 430 400 $68.85
83986 13 12 $62.82
84156 24 12 $60.95
J7050 Infusion, normal saline solution, 250 cc 13,364 8,606 $49.95
J3480 Injection, potassium chloride, per 2 meq 41 24 $48.60
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 188 159 $41.27
J2305 Injection, nitroglycerin, 5 mg 29 26 $36.92
J3475 Injection, magnesium sulfate, per 500 mg 74 62 $34.68
J0171 Injection, adrenalin, epinephrine, 0.1 mg 28 25 $34.09
J1956 Injection, levofloxacin, 250 mg 25 19 $31.05
J2919 Injection, methylprednisolone sodium succinate, 5 mg 170 128 $27.14
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 1,504 1,144 $24.81
J0780 Injection, prochlorperazine, up to 10 mg 105 92 $18.55
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg 13 12 $16.31
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 1,851 1,561 $15.84
J2470 Injection, pantoprazole sodium, 40 mg 111 82 $15.67
J0736 Injection, clindamycin phosphate, 300 mg 45 38 $14.59
97116 526 322 $11.47
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 81 55 $9.75
J1171 Injection, hydromorphone, 0.1 mg 103 87 $2.38
J0595 Injection, butorphanol tartrate, 1 mg 14 14 $2.11
C9113 Injection, pantoprazole sodium, per vial 1,409 900 $2.02
J3486 Injection, ziprasidone mesylate, 10 mg 48 41 $1.29
J2003 Injection, lidocaine hydrochloride, 1 mg 103 98 $0.60
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 377 366 $0.52
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 456 404 $0.32
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 137 119 $0.19
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 137 119 $0.19
96367 15 14 $0.00
92610 34 26 $0.00
J3490 Unclassified drugs 381 329 $0.00
36416 122 103 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 136 126 $0.00
99153 Mod sedat endo service >5yrs 43 40 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 58 31 $0.00
J1805 Injection, esmolol hydrochloride, 10 mg 53 48 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 36 32 $0.00